Butyrylcholinesterase deficiency
Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene.
<span class="disease" id="25054547-1-0-32">Butyrylcholinesterase deficiency</span> is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the <span class="gene" id="25054547-1-171-175">BCHE</span> gene.